The reciprocal link between EVI1 and miRNAs in human malignancies

被引:6
|
作者
Lang, Wen-Jing [1 ]
Chen, Fang-Yuan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200127, Peoples R China
基金
中国国家自然科学基金;
关键词
Ecotropic virus integration site-1 (EVI1); Non-coding RNAs; MicroRNAs; Transcription factor; Reciprocal link; Human malignancies; ACUTE MYELOID-LEUKEMIA; NEGATIVE FEEDBACK LOOP; VIRAL INTEGRATION SITE; BREAST-CANCER CELLS; DOWN-REGULATION; MICRORNA EXPRESSION; OVARIAN-CANCER; TUMOR-SUPPRESSOR; LUNG-CANCER; PANCREATIC CARCINOGENESIS;
D O I
10.1016/j.gene.2018.06.005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Ecotropic virus integration site-1 (EVI1) is an oncogenic transcription factor which locus on chromosome 3(3q26.2). Alterations in EVIL functions correspond with poor prognosis in different cancers, underscoring their status for the clinical cancer phenotype. MicroRNAs(MiR)are a class of small non-coding RNA sequences. They post-transcriptionally influence mRNA sequence through imperfect pairing with the 3'-UTR. Moreover, a growing body of studies showed that miRNAs could regulate initiation and progression of human malignancies. Current studies have been described that identifies numerous microRNAs that can be modulated by EVIl. Interestingly, the expression level of EVIl can also be regulated by microRNAs, thus forming a reciprocal link. Recent understanding of the functional roles of EVI1, microRNAs, and their interactions in human cancers are summarized. This review will help to define a relationship between EVI1 and microRNAs in human malignancies and develop novel therapeutic strategies.
引用
收藏
页码:56 / 63
页数:8
相关论文
共 50 条
  • [1] The role of EVI1 in myeloid malignancies
    Glass, Carolyn
    Wilson, Michael
    Gonzalez, Ruby
    Zhang, Yi
    Perkins, Archibald S.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2014, 53 (1-2) : 67 - 76
  • [2] Dysregulated EVI1 expression in myeloid malignancies
    Pardanani, Animesh
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (12) : 2443 - 2444
  • [3] PATHOGENETIC SIGNIFICANCE OF EVI1 IN MYELOID MALIGNANCIES
    Kurokawa, M.
    [J]. EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S105 - S105
  • [4] EVI1 overexpression in a serie of 212 hematological malignancies
    Luzardo, H.
    Gomez-Casares, M. T.
    Gonzalez-San Miguel, J. D.
    Lopez-Brito, J.
    Calvo-Vias, J. M.
    Molines, A.
    De La Iglesia, S.
    Caballero, A.
    Lopez-Jorge, C. E.
    Santana, G.
    Suarez, A.
    Molero, T.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 61 - 61
  • [5] EVI1 dysregulation: impact on biology and therapy of myeloid malignancies
    Birdwell, Christine
    Fiskus, Warren
    Kadia, Tapan M.
    DiNardo, Courtney D.
    Mill, Christopher P.
    Bhalla, Kapil N.
    [J]. BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [6] EVI1 dysregulation: impact on biology and therapy of myeloid malignancies
    Christine Birdwell
    Warren Fiskus
    Tapan M. Kadia
    Courtney D. DiNardo
    Christopher P. Mill
    Kapil N. Bhalla
    [J]. Blood Cancer Journal, 11
  • [7] Reply to Vazquez et al.: MicroRNA deregulation by EVI1 in human and murine malignancies
    Nucifora, Giuseppina
    Senyuk, Vitalyi
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (44) : E169 - E170
  • [8] Repression of RUNX1 activity by EVI1: A new role of EVI1 in leukemogenesis
    Senyuk, Vitalyi
    Sinha, Kislay K.
    Li, Donglan
    Rinaldi, Ciro R.
    Yanamandra, Sastry
    Nucifora, Giuseppina
    [J]. CANCER RESEARCH, 2007, 67 (12) : 5658 - 5666
  • [9] EVI1 and MDS1/EVI1 Expression During Primary Human Hematopoietic Progenitor Cell Differentiation into Various Myeloid Lineages
    Steinleitner, Katarina
    Rampetsreiter, Paulina
    Koeffel, Rene
    Ramanathan, Gajalakshmi
    Mannhalter, Christine
    Strobl, Herbert
    Wieser, Rotraud
    [J]. ANTICANCER RESEARCH, 2012, 32 (11) : 4883 - 4889
  • [10] Amplification of EVI1 on cytogenetically cryptic double minutes as new mechanism for increased expression of EVI1
    Volkert, Sarah
    Schnittger, Susanne
    Zenger, Melanie
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    [J]. CANCER GENETICS, 2014, 207 (03) : 103 - 108